tm logo
TRB
Live/Registered
REGISTERED

on 02 Feb 2021

Last Applicant/ Owned by

CH-1227 Carouge Genève

Serial Number

79284012 filed on 11th Mar 2020

Registration Number

6258760 registered on 02th Feb 2021

in the Principal Register

Correspondent Address

Andrew M. Smith

Andrew M. Smith Resonate IP, LLC

Bend, OR 97709

UNITED STATES

Filing Basis

1. filing basis filed as 66 a

Disclaimer

NO DATA

TRB

pharmaceuticals, namely, anti-neurodegenerative, anti-neurotrophic, anti-antineurotoxic, neuroprotective and neurorestorative effect agents; pharmaceuticals, namely, immunopharmaceuticals; medical and veterinary preparations, namely, preparations for use in treating joint disease in horses, and antioxidants; pharmaceutical and medicinal preparations and substances for treating and preventing ophth Read More

Classification Information


Class [005]
Pharmaceutical Products


pharmaceuticals, namely, anti-neurodegenerative, anti-neurotrophic, anti-antineurotoxic, neuroprotective and neurorestorative effect agents; pharmaceuticals, namely, immunopharmaceuticals; medical and veterinary preparations, namely, preparations for use in treating joint disease in horses, and antioxidants; pharmaceutical and medicinal preparations and substances for treating and preventing ophthalmic, ocular, neurological, metabolic, dermatological, arthritic, cognitive, or sexual dysfunction-related conditions, disorders or diseases; pharmaceutical and medicinal preparations and substances for treating and preventing joint, ligament, tendon, cartilage, bone, damaged skin or tissue-related conditions, disorders or diseases; pharmaceutical and medicinal preparations and substances for the treatment of central or peripheral nervous system-related, spinal cord-related, or early stages of traumatic or acute vascular injury-related disorders and diseases; pharmaceutical and medicinal preparations and substances for the treatment of pain, inflammation, physical lesions, and wounds; analgesics; anti-inflammatories; medicines for the treatment of keratitis, Sjögren's syndrome or primary dry eye syndrome; medicines for use as surgical aid during cataract surgery procedures; medicines for the treatment of osteoarthritis and rheumatoid arthritis; medicines for the prevention of osteoporosis; medicines for the treatment of musculo-skeletal conditions, disorders or diseases; medicines for the treatment of tendinopathy; medicines for joint recovery after arthroscopy; medicines to help assist with the regeneration of ligament and tendon fibers; medicines for the treatment of immune system related diseases and disorders; medicines for the treatment of blepharitis, glaucoma, and degenerative eye pathologies; pharmaceutical drugs for the treatment of keratitis, Sjögren's syndrome or primary dry eye syndrome; pharmaceutical drugs for use as surgical aid during cataract surgery procedures; pharmaceutical drugs for the treatment of osteoarthritis and rheumatoid arthritis; pharmaceutical drugs for the prevention of osteoporosis; pharmaceutical drugs for the treatment of musculo-skeletal conditions, disorders or diseases; pharmaceutical drugs for the treatment of tendinopathy; pharmaceutical drugs for joint recovery after arthroscopy; pharmaceutical drugs to help assist with the regeneration of ligament and tendon fibers; pharmaceutical drugs for the treatment of immune system related diseases and disorders; pharmaceutical drugs for the treatment of blepharitis, glaucoma, and degenerative eye pathologies; therapeutic drugs for the treatment of keratitis, Sjögren's syndrome or primary dry eye syndrome; therapeutic drugs for use as surgical aid during cataract surgery procedures; therapeutic drugs for the treatment of osteoarthritis and rheumatoid arthritis; therapeutic drugs for the prevention of osteoporosis; therapeutic drugs for the treatment of musculo-skeletal conditions, disorders or diseases; therapeutic drugs for the treatment of tendinopathy; therapeutic drugs for joint recovery after arthroscopy; therapeutic drugs to help assist with the regeneration of ligament and tendon fibers; therapeutic drugs for the treatment of immune system related diseases and disorders, and therapeutic agents for the treatment of keratitis, Sjögren's syndrome or primary dry eye syndrome; therapeutic agents for use as surgical aid during cataract surgery procedures; therapeutic agents for the treatment of osteoarthritis and rheumatoid arthritis; therapeutic agents for the prevention of osteoporosis; therapeutic agents for the treatment of musculo-skeletal conditions, disorders or diseases; therapeutic agents for the treatment of tendinopathy; therapeutic agents for joint recovery after arthroscopy; therapeutic agents to help assist with the regeneration of ligament and tendon fibers; therapeutic agents for the treatment of immune system related diseases and disorders; transdermal patches featuring vitamins for increasing energy for medical use; biological cartilage, bone or skin tissue intended for subsequent implantation; biological preparations for medical or veterinary use, namely, for the treatment of infectious diseases; sanitary preparations for medical purposes; dietetic food and substances in the nature of food supplements and vitamins supplements all adapted for medical or veterinary use; food for babies; dietary supplements for humans and animals; meal replacements, namely, meal replacement bars adapted for medical use and meal replacement beverages adapted for medical use, and dietetic beverages adapted for medical and veterinary use; materials for dressings, namely, dressings for wounds, burns or surgery, adhesive bandages, gauze for dressings, pledgets; disinfectants


First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details


Serial Number

No 79284012

Mark Type

No Service/Collective Mark

Attorney Docket Number

No

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

Yes

66A Current

Yes

Current Basis

No

No Basis

No

Design Code(s)

26.01.12 -

Circles with bars, bands and lines

26.17.10 -

Zig-zag line(s)

26.17.25 -

Other lines, bands or bars

Legal History


Show more

Status DateAction Taken
18th Sep 2024CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED
30th Jun 2024CORRECTION TRANSACTION RECEIVED FROM IB
09th Jun 2024CHANGE OF NAME/ADDRESS REC'D FROM IB
26th Feb 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
26th Feb 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
26th Feb 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
30th May 2021FINAL DECISION TRANSACTION PROCESSED BY IB
18th May 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
18th May 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
18th May 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED